This site is intended for healthcare professionals

Specialty hub

Gastroenterology and Hepatology

Containing dedicated Learning Zones, guidelines, trials and news for related conditions in Gastroenterology and Hepatology.

Read time: 5 mins

Last updated: 23rd Nov 2021

Welcome:

Sign in/Register

Updates in your area
of interest

Articles your peers
are looking at

Bookmarks
saved

Days to your
next event

Gastroenterology is a branch of medicine that deals with normal function and diseases that affect the digestive tract, from mouth to anus and includes hepatology involving the study of the liver, pancreas, gallbladder and biliary tree.

Learning Zones

Inflammatory Bowel Disease Learning Zone

Inflammatory Bowel Disease Learning Zone

100 mins

Fluid Management Learning Zone

Learning Zone Homepage

Fluid Management Learning Zone

225 mins

Optimising anti-TNF treatment using biosimilars

Learning Zone Homepage

Optimising anti-TNF treatment using biosimilars

85 mins

Acute Hepatic Porphyria Learning Zone

Learning Zone Homepage

Acute Hepatic Porphyria Learning Zone

45 mins

Gastroenterology focuses on the diagnosis and treatment of conditions such gastrointestinal disorders including acute hepatic porphyria, bowel disorders including inflammatory bowel disease, Crohn’s disease, as well as Coeliac disease, hepatitis and pancreatic disorders or transplantation.

Diseases in this section

Bowel Disorders

Containing relevant Learning Zones, guidelines, trials and news.

Gastrointestinal Disorders

Containing relevant Learning Zones, guidelines, trials and news.

Solid Organ Transplantation

Containing relevant Learning Zones, guidelines, trials and news.

Related news and insights

Jyseleca approved for treatment of adult patients with moderate to severe ulcerative colitis in United Kingdom.

The MHRA has licensed an additional indication for Jyseleca, an oral once-daily, JAK1 preferential inhibitor from Galapagos NV, for use in adult patients with moderately to severely active Ulcerative Colitis who have had an inadequate response with, lost response to, or were intolerant to either conventional therapy or a biologic agent.

1 mins

EU approves AVT 02 as biosimilar to Humira.

Alvotech received approval for AVT 02 (100 mg/mL), the company’s high concentration biosimilar to Humira (adalimumab), from the European Commission (EC) on Nov 15.

1 min

Mirikizumab demonstrates superiority over placebo in phase III maintenance study in ulcerative colitis.

Eli Lilly and Company announced that mirikizumab met the primary endpoint of clinical remission and all key secondary endpoints at one year in LUCENT-2, a Phase III maintenance study evaluating the efficacy and safety of mirikizumab for the treatment of patients with moderately-to-severely active ulcerative colitis (UC).

2 min

See all news

Related Drugs

Ambirix, suspension for injection in pre-filled syringe (Northern Ireland)

Ambirix, suspension for injection in pre-filled syringe (Northern Ireland)

12 mins

Norimode (Loperamide) 2mg Tablets

Norimode (Loperamide) 2mg Tablets

9 mins

Zantac 75 Tablets

Zantac 75 Tablets

1 mins

Spasmonal Forte 120mg hard capsules

Spasmonal Forte 120mg hard capsules

1 mins

1 mins

Scopoderm 1.5 mg Patch

Scopoderm 1.5 mg Patch

1 mins

1 mins

Perinal Cutaneous Spray

Perinal Cutaneous Spray

1 mins

Percutol Ointment

Percutol Ointment

4 mins

Pantoloc Control 20mg gastro-resistant tablets

Pantoloc Control 20mg gastro-resistant tablets

1 mins

Pancrex V Tablets

Pancrex V Tablets

1 mins

Pancrex V Powder

Pancrex V Powder

1 mins

Pancrex V Forte Tablets

Pancrex V Forte Tablets

1 mins

Pancrex V Capsules 125mg

Pancrex V Capsules 125mg

1 mins

Pancrex Granules

Pancrex Granules

1 mins

Related Journals

Systematic Assessment of Adult Patients' Satisfaction with Various Eosinophilic Esophagitis Therapies

Systematic Assessment of Adult Patients' Satisfaction with Various Eosinophilic Esophagitis Therapies

1 mins

Efficacy of Therapy for Eosinophilic Esophagitis in Real-World Practice

Efficacy of Therapy for Eosinophilic Esophagitis in Real-World Practice

2 mins

Esophageal perforation in eosinophilic esophagitis: A systematic review on clinical presentation, management and outcomes

Esophageal perforation in eosinophilic esophagitis: A systematic review on clinical presentation, management and outcomes

1 mins

Helicobacter pylori infection does not protect against eosinophilic esophagitis: results from a large multicenter case-control study

Helicobacter pylori infection does not protect against eosinophilic esophagitis: results from a large multicenter case-control study

1 mins

Emerging incidence trends of eosinophilic esophagitis over 25 years: Results of a nationwide register-based pathology cohort

Emerging incidence trends of eosinophilic esophagitis over 25 years: Results of a nationwide register-based pathology cohort

1 mins

Incidence and prevalence of eosinophilic oesophagitis increase continiously in adults and children in Central Spain: A 12-year population-based study

Incidence and prevalence of eosinophilic oesophagitis increase continiously in adults and children in Central Spain: A 12-year population-based study

1 mins

Efficacy of proton pump inhibitor therapy for eosinophilic oesophagitis in 630 patients: results from the EoE connect registry

Efficacy of proton pump inhibitor therapy for eosinophilic oesophagitis in 630 patients: results from the EoE connect registry

1 mins

Food-induced immediate response of the esophagus-A newly identified syndrome in patients with eosinophilic esophagitis

Food-induced immediate response of the esophagus-A newly identified syndrome in patients with eosinophilic esophagitis

1 mins

Orodispersible budesonide tablets for the treatment of eosinophilic esophagitis: a review of the latest evidence

Orodispersible budesonide tablets for the treatment of eosinophilic esophagitis: a review of the latest evidence

1 mins

Budesonide Orodispersible Tablets Maintain Remission in a Randomized, Placebo-Controlled Trial of Patients With Eosinophilic Esophagitis

Budesonide Orodispersible Tablets Maintain Remission in a Randomized, Placebo-Controlled Trial of Patients With Eosinophilic Esophagitis

1 mins

Related Guidelines

Dietary Therapy and Nutrition Management of Eosinophilic Esophagitis: A Work Group Report of the American Academy of Allergy, Asthma, and Immunology

This work group report addresses the potential challenges of implementing an elimination diet for the management of EoE and provides instructions and tools for physicians, dietitians, and other allied health professionals to help guide them in planning elimination diets for both children and adults.

1 mins

Updated International Consensus Diagnostic Criteria for Eosinophilic Esophagitis: Proceedings of the AGREE Conference

We aimed to clarify the use of PPIs in the evaluation and treatment of children and adults with suspected EoE to develop updated international consensus criteria for EoE diagnosis.

1 min

AGA Institute and the Joint Task Force on Allergy-Immunology Practice Parameters Clinical Guidelines for the Management of Eosinophilic Esophagitis

This document presents the official recommendations of the American Gastroenterological Association (AGA) and the Joint Task Force on Allergy-Immunology Practice Parameters (JTF) on the management of eosinophilic esophagitis.

1 min

See all guidelines

Related Clinical Trials

A Study to Assess the Efficacy, Safety and Tolerability of IRL201104 in Adults With Active Eosinophilic Esophagitis

A Study to Assess the Efficacy, Safety and Tolerability of IRL201104 in Adults With Active Eosinophilic Esophagitis

1 mins

Efficacy and Safety APT-1011 in Adult Subjects With Eosinophilic Esophagitis (EoE) (FLUTE-2)

Efficacy and Safety APT-1011 in Adult Subjects With Eosinophilic Esophagitis (EoE) (FLUTE-2)

1 mins

Safety Study of CC-93538 in Adult and Adolescent Participants With Eosinophilic Esophagitis

Safety Study of CC-93538 in Adult and Adolescent Participants With Eosinophilic Esophagitis

1 mins

A Study to Assess the Safety and Efficacy of Oral Etrasimod in Adult Participants With Eosinophilic Esophagitis (VOYAGE)

A Study to Assess the Safety and Efficacy of Oral Etrasimod in Adult Participants With Eosinophilic Esophagitis (VOYAGE)

1 mins

A Study of Lirentelimab (AK002) in Patients With Active Eosinophilic Esophagitis (KRYPTOS)

A Study of Lirentelimab (AK002) in Patients With Active Eosinophilic Esophagitis (KRYPTOS)

1 mins

A Study of Benralizumab in Patients With Eosinophilic Esophagitis (MESSINA)

A Study of Benralizumab in Patients With Eosinophilic Esophagitis (MESSINA)

1 mins

Maintenance of Remission With Budesonide Orodispersible Tablets vs. Placebo in Eosinophilic Esophagitis (EOS-2)

Maintenance of Remission With Budesonide Orodispersible Tablets vs. Placebo in Eosinophilic Esophagitis (EOS-2)

1 mins

Study to Investigate the Efficacy and Safety of Dupilumab in Pediatric Patients With Active Eosinophilic Esophagitis (EoE) (EoE KIDS)

Study to Investigate the Efficacy and Safety of Dupilumab in Pediatric Patients With Active Eosinophilic Esophagitis (EoE) (EoE KIDS)

1 mins

Study to Determine the Efficacy and Safety of Dupilumab in Adult and Adolescent Patients With Eosinophilic Esophagitis (EoE)

Study to Determine the Efficacy and Safety of Dupilumab in Adult and Adolescent Patients With Eosinophilic Esophagitis (EoE)

1 mins

Pilot Study Using a Dietary Intervention for Children With Irritable Bowel Syndrome

Pilot Study Using a Dietary Intervention for Children With Irritable Bowel Syndrome

1 mins

Phase 3 Study of Bulevirtide in Patients With CHD

Phase 3 Study of Bulevirtide in Patients With CHD

3 mins

Impact of Medical Treatment on Sexual Function in Patients With Crohn's Disease

Impact of Medical Treatment on Sexual Function in Patients With Crohn's Disease

1 mins

Related Events

Digestive Disease Week (DDW 2022)

Digestive Disease Week (DDW 2022)

1 mins

The 53rd ESPGHAN June 22 - 25, 2022 in Copenhagen, Denmark

The 53rd ESPGHAN June 22 - 25, 2022 in Copenhagen, Denmark

1 mins

The International Society for Disease of the Esophagus (ISDE) 2022 World Congress

The International Society for Disease of the Esophagus (ISDE) 2022 World Congress

1 mins

World Congress of Gastroenterology 12th - 14th Dec 2022

World Congress of Gastroenterology 12th - 14th Dec 2022

1 mins

Your peers are looking at...

Efficacy of Plasmapheresis in Nivolumab-Associated ANCA Glomerulonephritis: A Case Report and Pathophysiology Discussion

Efficacy of Plasmapheresis in Nivolumab-Associated ANCA Glomerulonephritis: A Case Report and Pathophysiology Discussion

1 mins

KM55 Monoclonal Antibody Staining in IgA-Dominant Infection-Related Glomerulonephritis

KM55 Monoclonal Antibody Staining in IgA-Dominant Infection-Related Glomerulonephritis

1 mins

Transforming Growth Factor-β1/Smad Signaling in Glomerulonephritis and Its Association with Progression to Chronic Kidney Disease

Transforming Growth Factor-β1/Smad Signaling in Glomerulonephritis and Its Association with Progression to Chronic Kidney Disease

1 mins

Rituximab or Cyclophosphamide in the Treatment of Membranous Nephropathy: The RI-CYCLO Randomized Trial

Rituximab or Cyclophosphamide in the Treatment of Membranous Nephropathy: The RI-CYCLO Randomized Trial

1 mins

Mechanisms of Primary Membranous Nephropathy

Mechanisms of Primary Membranous Nephropathy

1 mins

Membranous nephropathy: current understanding of various causes in light of new target antigens

Membranous nephropathy: current understanding of various causes in light of new target antigens

1 mins

Advances in Membranous Nephropathy

Advances in Membranous Nephropathy

1 mins

IgA Vasculitis and IgA Nephropathy: Same Disease?

IgA Vasculitis and IgA Nephropathy: Same Disease?

1 mins

Complement activation in IgA nephropathy

Complement activation in IgA nephropathy

1 mins

MicroRNAs in IgA nephropathy

MicroRNAs in IgA nephropathy

1 mins